Familial gastrointestinal stromal tumors, lentigines, and café‐au‐lait macules associated with germline <i>c‐kit</i> mutation treated with imatinib

Abstract

A c-kit mutational test in familial GISTs is indicated before initiation of imatinib therapy, as it can help predict tumor response to treatment.